Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.
Iyengar P, Zhang-Velten E, Court L, Westover K, Yan Y, Lin MH, Xiong Z, Patel M, Rivera D, Chang J, Saunders M, Shivnani A, Lee A, Hughes R, Gerber D, Dowell J, Gao A, Heinzerling J, Li Y, Ahn C, Choy H, Timmerman R.
JAMA Oncol. 2021 Oct 1;7(10):1497-1505. doi: 10.1001/jamaoncol.2021.3186.
PMID:34383006
The role of biologically effective dose (BED) in clinical oncology.
Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA.
Spatiotemporal fractionation schemes for stereotactic radiosurgery of multiple brain metastases.
Torelli N, Papp D, Unkelbach J.
Med Phys. 2023 Aug;50(8):5095-5114. doi: 10.1002/mp.16457. Epub 2023 Jun 15.
PMID:37318898
Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
Redmond KJ, De Salles AAF, Fariselli L, Levivier M, Ma L, Paddick I, Pollock BE, Regis J, Sheehan J, Suh J, Yomo S, Sahgal A.
Large variation in radiation therapy fractionation for multiple myeloma in Australia.
Ong WL, MacManus M, Milne RL, Foroudi F, Millar JL.
Asia Pac J Clin Oncol. 2023 Feb;19(1):149-157. doi: 10.1111/ajco.13783. Epub 2022 May 22.
PMID:35599450
Re-irradiation of multiple brain metastases using CyberKnife stereotactic radiotherapy: Case report.
Zhou H, Wu T, Zhu X, Li Y.
Medicine (Baltimore). 2021 Oct 15;100(41):e27543. doi: 10.1097/MD.0000000000027543.
PMID:34731155
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza D, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, Chen Y, Rodgers JP, Sandler HM.